Johnen, Andreas
Pawlowski, Matthias
Duning, Thomas
Article History
Received: 26 January 2018
Accepted: 29 May 2018
First Online: 5 June 2018
Ethics approval and consent to participate
: All patients included in the study provided written informed consent. The study protocol was approved by the local ethics committee (2012–365-f-S), and was developed in accordance with the 1975 Helsinki declaration, as revised in 2000.
: TD has received speaker honoraria, consultancy fees, and travel expenses from Genzyme, Shire, Sanofi Aventis, Novartis, Actelion Pharmaceuticals and Amicus, research support from Genzyme, Shire, Amicus and Actelion Pharmaceuticals, and educational grants from Novartis, Roche and Biogen. AJ received travel expenses from Actelion Pharmaceuticals.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.